PhD Marko Snoj

PhD Marko Snoj
no.: 12250 source: ARIS

researcher – retired
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • French
  • Reading: Functional
  • Writing: Functional
  • Speaking: Functional
Edit
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
Keywords
Oncology, phospholipase A2, metastasizing
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
204.95
A''
29.65
A'
29.65
A1/2
44.67
CI10
3,485
CImax
1,533
h10
17
A1
0.62
A3
1.78
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020, 2021, 2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 48  4,132  3,474  72.38 
Scopus 52  5,027  4,279  82.29 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Nebojša Glumac   Uniform doctoral studies  1/1/2003 - 12/31/2008  23342 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   10/1/2021 - 9/30/2025  PhD Gregor Serša   7,319 
2. J3-6796  Translacijska onkologija: razvoj in validacija imunsko genske terapije z interleukinom-12 v kombinaciji s kirurgijo pri oralnih in kožnih tumorjih psov (Slovene)   7/1/2014 - 6/30/2017  PhD Maja Čemažar   5,190 
3. J3-4211  Antiangiogena genska terapija raka: tarčno zdravljenje z uporabo elektroporacije in magnetnih nanodelcev kot dostavnih sistemov (Slovene)   7/1/2011 - 6/30/2014  PhD Gregor Serša   6,891 
4. J3-4259  Priprava in validacija terapevtskih plazmidov brez selekcijskega gena za antibiotično rezistenco za gensko terapijo raka z inducibilnimi in tkivno specifičnimi promotorji (Slovene)   7/1/2011 - 6/30/2014  PhD Maja Čemažar   6,296 
5. L3-4278  Po odstranitvi varovalne bezgavke: Obsevanje ali kirurgija (Slovene)   7/1/2002 - 6/30/2005  PhD Marko Snoj   1,869 
6. J3-3501  Creation of tumor vaccines   7/1/2001 - 6/30/2004  PhD Srdjan Novaković   3,630 
7. J3-3464  Role of tyrosinase RT-PCR in staging of patients with malignant melanoma   7/1/2001 - 6/30/2004  PhD Marko Hočevar   2,886 
8. L3-2161  Varovalna bezgavka (Slovene)   1/1/2000 - 6/30/2002  PhD Marko Snoj   1,465 
9. L3-1192  PovejMi: telemedicinska pomoč bolnicam z rakom dojke (Slovene)   1/1/1999 - 6/30/2001  PhD Ankica Babič   3,838 
10. J3-7878  Razvoj avtolognih tumorskih vakcin (Slovene)   1/1/1996 - 6/30/2001  PhD Srdjan Novaković   5,905 
11. J3-8744  Phospholipase a2 in tumor tissue   1/1/1997 - 12/31/1999  PhD Marko Snoj   1,201 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2022 - 12/31/2027 PhD Gregor Serša   4,393 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2015 - 12/31/2021 PhD Gregor Serša   3,528 
3. P3-0321  Prognostic and predictive factors for response in treatment of breast cancer and other cancers   1/1/2009 - 12/31/2014 PhD Barbara Jezeršek Novaković   3,990 
4. P3-0321  Prognostic and predictive factors for response in treatment of breast cancer and other cancers   7/1/2004 - 12/31/2008 PhD Tanja Čufer   3,751 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite